Provided by Tiger Trade Technology Pte. Ltd.

bioAffinity Technologies, Inc.

8.56
+0.855011.10%
Post-market: 8.630.0750+0.88%19:53 EDT
Volume:874.30K
Turnover:7.47M
Market Cap:5.14M
PE:-0.08
High:9.14
Open:8.28
Low:8.26
Close:7.70
52wk High:109.35
52wk Low:4.56
Shares:600.70K
Float Shares:593.10K
Volume Ratio:0.12
T/O Rate:147.41%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-103.3536
EPS(LYR):-129.9452
ROE:-1860.15%
ROA:-125.11%
PB:1.36
PE(LYR):-0.07

Loading ...

BioAffinity will present preclinical findings on small interfering RNAs

TIPRANKS
·
Jun 22

bioAffinity reports positive preclinical data for siRNA therapy targeting squamous, basal skin cancer cells

Reuters
·
Jun 22

bioAffinity Technologies Reports Positive Preclinical Findings Showing Proprietary Gene Silencing Technology Is Selectively Cytotoxic to Squamous Skin Cancer Cells Without Harming Healthy Cells

THOMSON REUTERS
·
Jun 22

BioAffinity Technologies Closes $3.2 Million Public Offering

MT Newswires Live
·
Jun 19

bioAffinity Technologies closes USD 3.2 million follow-on offering priced at USD 0.8 per share

Reuters
·
Jun 19

bioAffinity Technologies Announces Closing of $3.2 Million Offering

THOMSON REUTERS
·
Jun 19

bioAffinity Technologies Prices $3.2 Million Offering; Shares Drop 13%

MT Newswires Live
·
Jun 17

BioAffinity Technologies prices 4M shares at 80c in public offering

TIPRANKS
·
Jun 17

bioAffinity Technologies prices USD 3.2 million public offering at USD 0.8 per share

Reuters
·
Jun 17

bioAffinity Technologies Announces Pricing of $3.2 Million Offering

THOMSON REUTERS
·
Jun 17

BioAffinity announces webinar for program to advance veteran lung health

TIPRANKS
·
Jun 16

bioAffinity Technologies to host veteran lung health screening webinar with Philips, 4DMedical

Reuters
·
Jun 16

BRIEF-Bioaffinity Technologies - Offers 2.63 Million Shares Of Common Stock - SEC Filing

Reuters
·
Jun 13

bioAffinity Technologies - Offers 2.63 Mln Shares of Common Stock - SEC Filing

THOMSON REUTERS
·
Jun 13

bioAffinity Technologies - Assumed Public Offering Price Set at $1.52 per Share - SEC Filing

THOMSON REUTERS
·
Jun 13

bioAffinity to present CyPath Lung test in Society for Advanced Bronchoscopy webinar

Reuters
·
Jun 02

BioAffinity Technologies announces notification of Mexico patent allowance

TIPRANKS
·
May 27

bioAffinity Technologies says Mexico allows patent covering CyPath Lung cancer detection methods

Reuters
·
May 27

bioAffinity Technologies Announces Notification of Mexico Patent Allowance Covering Novel Lung Cancer Detection Methods Using Cypath® Lung Technology

THOMSON REUTERS
·
May 27

bioAffinity reports April CyPath Lung unit sales jump nearly 300% year over year

Reuters
·
May 12